AGREEMENT AND PLAN OF MERGERMerger Agreement • April 5th, 2021 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of April 2, 2021 (the “Agreement Date”), is among Sorrento Therapeutics, Inc., a Delaware corporation (the “Parent”), AT Merger Sub, Inc., an exempted company incorporated with limited liability in the Cayman Islands with the registration number 372993 and wholly owned subsidiary of Parent (“Merger Sub”), ACEA Therapeutics, Inc., an exempted company incorporated with limited liability in the Cayman Islands with the registration number 351589 (the “Company”), and Fortis Advisors LLC, a Delaware limited liability company, as the Shareholders’ Representative (as defined in Section 10.14(a)). Certain other capitalized terms used herein are defined in Section 1.1 and Section 1.2.
